TheraCal PT® Dual-Syringe
Bisco, Inc. · #H-34110P
Automatisch erfasst von bisco.com
Sie sind der Hersteller?Daten liefern
Herstellertext auf Englisch
Dual-Cured Resin-Modified Calcium Silicate Pulpotomy TreatmentTheraCal PT is a part of BISCO’s award winning THERA Family. It is a biocompatible, dual-cured, resin-modified calcium silicate designed for pulpotomy treatment. TheraCal PT maintains tooth vitality by performing as a barrier and protector of the dentin pulp complex. Its unique hydrophilic matrix facilitates calcium release* and generates an alkaline pH at 7 days which promotes pulp vitality.*1 There is no need to mix material by hand as it is delivered via a dual barrel, auto-mix syringe. Confidently place TheraCal PT in 1 office visit with quick working and setting times (WT = 45 seconds at 35°C (min.) ST = 5 minutes at 35°C). 4g syringe of TheraCal PT can provide approximately 12-15 pulpotomy applications. Unique Benefits:
Minimum Working Time of 45 seconds at 35°C and maximum Setting Time of 5 minutes at 35°C
Unique hydrophilic matrix facilitates calcium release*
Generates an Alkaline pH at 7 days*
Radiopaque for easy identification and differentiation from recurrent decay and other restorative materials.*
Easy syringe application means no mixing by hand
Dual-cured for one-layer confidence
Moisture tolerant – low water solubility*
Clinical Significance:
The chemical formulation of TheraCal PT consists of synthetic Portland Cement calcium silicate particles in a hydrophilic matrix which facilitates calcium release*
Pro Tip:
Light-curing TheraCal PT for 10 seconds after placement will allow the clinician to restore in a single visit.
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 10.0px 'Lucida Grande'} p.p2 {margin: 0.0px 0.0px 0.0px 0.0px; font: 10.0px 'Lucida Grande'; min-height: 12.0px}
Produktinformationen
| Hersteller | Bisco, Inc. |
|---|---|
| Farbe | A1/Natural |
| Format | Dual barrel, auto-mix syringe |
| Material | Dual-cured, resin-modified calcium silicate |
| Eigenschaften | Biocompatible, moisture tolerant, low water solubility, radiopaque, alkaline pH |
| Haltbarkeit | 18 Months |
| Indikationen | Pulpotomies (primary), direct and indirect pulp capping, liner or base |
| Produkttyp | Pulpotomy Treatment |
| Abbindezeit | Maximum 5 minutes at 35°C |
| Syringe Size | 4g |
| Verarbeitungszeit | Minimum 45 seconds at 35°C |
| Storage Temperature | Room temperature (68°-77° F; 20°-25° C) |
Dokumente
- TheraCal PT Rev 5 22 2024-10-09-08-34-00-2024-10-09-20-34-01-262Dokument
- TheraCal PT Archive Rev 9-21 2024-10-09-08-34-39-2024-10-09-20-34-39-473Dokument
- TheraCal PT Archive Rev 5-20 2024-10-09-08-34-59-2024-10-09-20-35-00-354Dokument
- TheraCal PT Archive Rev 11-19 2024-10-09-08-35-24-2024-10-09-20-35-24-627Dokument
- TheraCal PT Archive Rev 4-19 2024-10-09-08-35-52-2024-10-09-20-35-52-827Dokument
- TheraCal PT Brochure 2025-03-20-06-12-58-2025-03-20-18-12-58-888Broschüre
- TheraCal PT 5 Reasons 2024-10-09-08-26-54-2024-10-09-20-26-54-918Dokument
- TheraCal PT Comparison 2024-10-09-08-29-36-2024-10-09-20-29-36-481Dokument
und 61 weitere